SFEMG in ocular myasthenia gravis diagnosis.

PubWeight™: 1.06‹?› | Rank: Top 15%

🔗 View Article (PMID 10880794)

Published in Clin Neurophysiol on July 01, 2000

Authors

L Padua1, E Stalberg, M LoMonaco, A Evoli, A Batocchi, P Tonali

Author Affiliations

1: Department of Neurology, Università Cattolica, Rome, Italy. lpadua@mclink.it

Articles by these authors

Dopamine dependency of oscillations between subthalamic nucleus and pallidum in Parkinson's disease. J Neurosci (2001) 3.18

Natural history of young-adult amyotrophic lateral sclerosis. Neurology (2008) 3.13

Magnetic transcranial stimulation at intensities below active motor threshold activates intracortical inhibitory circuits. Exp Brain Res (1998) 2.90

Short latency inhibition of human hand motor cortex by somatosensory input from the hand. J Physiol (2000) 2.41

Genetic homogeneity between childhood-onset and adult-onset autosomal recessive spinal muscular atrophy. Lancet (1995) 2.40

Propagation velocity in human muscle fibers in situ. Acta Physiol Scand Suppl (1966) 2.36

Effects of voluntary contraction on descending volleys evoked by transcranial stimulation in conscious humans. J Physiol (1998) 2.17

Guidelines for treatment of autoimmune neuromuscular transmission disorders. Eur J Neurol (2010) 2.03

Progress in the molecular diagnosis of facioscapulohumeral muscular dystrophy and correlation between the number of KpnI repeats at the 4q35 locus and clinical phenotype. Ann Neurol (1999) 1.95

Comparison of descending volleys evoked by transcranial magnetic and electric stimulation in conscious humans. Electroencephalogr Clin Neurophysiol (1998) 1.90

Thymus changes in anti-MuSK-positive and -negative myasthenia gravis. Neurology (2005) 1.89

Different mutations in the LMNA gene cause autosomal dominant and autosomal recessive Emery-Dreifuss muscular dystrophy. Am J Hum Genet (2000) 1.84

Direct demonstration of the effect of lorazepam on the excitability of the human motor cortex. Clin Neurophysiol (2000) 1.80

Contribution of ultrasound in a neurophysiological lab in diagnosing nerve impairment: A one-year systematic assessment. Clin Neurophysiol (2007) 1.79

Direct demonstration of interhemispheric inhibition of the human motor cortex produced by transcranial magnetic stimulation. Exp Brain Res (1999) 1.69

Multiperspective follow-up of untreated carpal tunnel syndrome: a multicenter study. Neurology (2001) 1.68

Coenzyme Q10 reverses pathological phenotype and reduces apoptosis in familial CoQ10 deficiency. Neurology (2001) 1.68

Chronic subthalamic nucleus stimulation reduces medication requirements in Parkinson's disease. Neurology (1999) 1.66

GCG genetic expansions in Italian patients with oculopharyngeal muscular dystrophy. Neurology (2000) 1.64

Analysis of blink rate patterns in normal subjects. Mov Disord (1997) 1.57

Neurophysiological classification and sensitivity in 500 carpal tunnel syndrome hands. Acta Neurol Scand (1997) 1.57

Apoptotic features accompany acute quadriplegic myopathy. Neurology (2000) 1.57

Calculation of the electromyographic jitter. J Neurol Neurosurg Psychiatry (1974) 1.49

Clinical characteristics and prognosis of myasthenia gravis in older people. J Am Geriatr Soc (2000) 1.48

Variables influencing quality of life and disability in Charcot Marie Tooth (CMT) patients: Italian multicentre study. Neurol Sci (2006) 1.48

Mononeuropathy of a distal branch of the femoral nerve in a body building champion. J Neurol Neurosurg Psychiatry (1997) 1.47

Outcome research and patient-oriented measures in the multiperspective assessment of neurological and musculoskeletal disorders. Consensus Conference: Third Roman Neurophysiology Day, Outcome Research in Neurology and in Musculoskeletal Disorders--24 October 1998. Ital J Neurol Sci (1999) 1.47

A systematic review of conservative treatment of carpal tunnel syndrome. Clin Rehabil (2007) 1.46

Muscarinic receptor blockade has differential effects on the excitability of intracortical circuits in the human motor cortex. Exp Brain Res (2000) 1.42

Acetylcholine receptor M3 domain: stereochemical and volume contributions to channel gating. Nat Neurosci (1999) 1.42

Pretarsal injections of botulinum toxin improve blepharospasm in previously unresponsive patients. J Neurol Neurosurg Psychiatry (1996) 1.41

Teaching NeuroImages: the full-blown neuroimaging of Wernicke encephalopathy. Neurology (2009) 1.39

Intracortical origin of the short latency facilitation produced by pairs of threshold magnetic stimuli applied to human motor cortex. Exp Brain Res (1999) 1.38

Occurrence of nerve entrapment lesion in chronic inflammatory demyelinating polyneuropathy. Clin Neurophysiol (2004) 1.38

A useful electrophysiological test for diagnosis of minimal conduction block. Clin Neurophysiol (2001) 1.38

The effect on corticospinal volleys of reversing the direction of current induced in the motor cortex by transcranial magnetic stimulation. Exp Brain Res (2001) 1.34

Specificity of calcium channel autoantibodies in Lambert-Eaton myasthenic syndrome. Lancet (1989) 1.33

Impairment of skeletal muscle adenosine triphosphate-sensitive K+ channels in patients with hypokalemic periodic paralysis. J Clin Invest (1999) 1.25

[On the neuromuscular block caused by intra-arterial injection of acetylcholine. Effects of preliminary treatment with ACTH]. Riv Neurol (1971) 1.24

Neurophysiological assessment in the diagnosis of botulism: usefulness of single-fiber EMG. Muscle Nerve (1999) 1.21

EFNS guideline on diagnosis and management of post-polio syndrome. Report of an EFNS task force. Eur J Neurol (2006) 1.20

Guidelines for the treatment of autoimmune neuromuscular transmission disorders. Eur J Neurol (2006) 1.19

Fundamental gating mechanism of nicotinic receptor channel revealed by mutation causing a congenital myasthenic syndrome. J Gen Physiol (2000) 1.18

Effects of lorazepam on short latency afferent inhibition and short latency intracortical inhibition in humans. J Physiol (2005) 1.17

Reduced habituation to experimental pain in migraine patients: a CO(2) laser evoked potential study. Pain (2003) 1.14

F responses studied with single fibre EMG in normal subjects and spastic patients. J Neurol Neurosurg Psychiatry (1978) 1.14

Suprascapular nerve entrapment. Neurophysiological localization in 6 cases. Acta Orthop Scand (1996) 1.13

Long-term follow up of subthalamic nucleus stimulation in Parkinson's disease. Neurology (2002) 1.13

Giant dystrophin deletion associated with congenital cataract and mild muscular dystrophy. Neurology (1998) 1.12

Gamma1- and gamma2-syntrophins, two novel dystrophin-binding proteins localized in neuronal cells. J Biol Chem (2000) 1.10

Dominantly inherited mitochondrial myopathy with multiple deletions of mitochondrial DNA: clinical, morphologic, and biochemical studies. Neurology (1991) 1.10

Incidence of bilateral symptoms in carpal tunnel syndrome. J Hand Surg Br (1998) 1.10

Myasthenia gravis during interferon alfa therapy. Neurology (1995) 1.10

Assessment of health status in children with spina bifida. Spinal Cord (2005) 1.09

Neurophysiological classification of carpal tunnel syndrome: assessment of 600 symptomatic hands. Ital J Neurol Sci (1997) 1.09

Effects of voluntary contraction on descending volleys evoked by transcranial electrical stimulation over the motor cortex hand area in conscious humans. Exp Brain Res (1999) 1.09

EFNS/ENS Guidelines for the treatment of ocular myasthenia. Eur J Neurol (2014) 1.06

Comparison of descending volleys evoked by monophasic and biphasic magnetic stimulation of the motor cortex in conscious humans. Exp Brain Res (2001) 1.04

MHC class I, MHC class II and intercellular adhesion molecule-1 (ICAM-1) expression in inflammatory myopathies. Clin Exp Immunol (1994) 1.04

Descending spinal cord volleys evoked by transcranial magnetic and electrical stimulation of the motor cortex leg area in conscious humans. J Physiol (2001) 1.03

Cisplatin neuropathy: clinical course and neurophysiological findings. J Neurol (1992) 1.03

Ocular myasthenia: diagnostic and therapeutic problems. Acta Neurol Scand (1988) 1.03

Predictive variables on disability and quality of life in stroke outpatients undergoing rehabilitation. Neurol Sci (2006) 1.02

Botulinum toxin as a treatment for blepharospasm, spasmodic torticollis and hemifacial spasm. Eur Neurol (1992) 1.02

Retroviral vector-mediated gene transfer into human primary myogenic cells leads to expression in muscle fibers in vivo. Hum Gene Ther (1993) 1.01

Clinical electrophysiology in myasthenia gravis. J Neurol Neurosurg Psychiatry (1980) 1.01

Pre-movement facilitation of motor-evoked potentials in man during transcranial stimulation of the central motor pathways. Brain Res (1988) 1.00

Thymic lesions and myasthenia gravis. Diagnosis based on mediastinal imaging and pathological findings. Acta Radiol (2002) 0.99

Thymectomy in the treatment of myasthenia gravis: report of 247 patients. J Neurol (1988) 0.99

A multicentre follow-up study of 1152 patients with myasthenia gravis in Italy. J Neurol (1990) 0.99

Natural history of CMT1A including QoL: a 2-year prospective study. Neuromuscul Disord (2008) 0.99

Apoptosis in mitochondrial encephalomyopathies with mitochondrial DNA mutations: a potential pathogenic mechanism. Brain (2000) 0.98

Cerebro-cerebellar interactions in man: neurophysiological studies in patients with focal cerebellar lesions. Electroencephalogr Clin Neurophysiol (1994) 0.97

A late-onset mitochondrial myopathy is associated with a novel mitochondrial DNA (mtDNA) point mutation in the tRNA(Trp) gene. Neuromuscul Disord (1998) 0.97

Topiramate in migraine prophylaxis: a randomised double-blind versus placebo study. Neurol Sci (2004) 0.96

Multiple system atrophy presenting as parkinsonism: clinical features and diagnostic criteria. J Neurol Neurosurg Psychiatry (1995) 0.96

Recovery after surgery of the spinal N24 SEP in dural arteriovenous malformation of the dorsal cord. Electroencephalogr Clin Neurophysiol (1995) 0.96

Cardiomyopathy may be the only clinical manifestation in female carriers of Duchenne muscular dystrophy. Neurology (1993) 0.96

Prognosis of myasthenia gravis: a multicenter follow-up study of 844 patients. J Neurol Sci (1991) 0.96

Peripheral neuropathy with giant axons and cardiomyopathy associated with desmin type intermediate filaments in skeletal muscle. J Neurol Sci (1992) 0.96

Neurophysiological predictors of long term response to AChE inhibitors in AD patients. J Neurol Neurosurg Psychiatry (2005) 0.95

Severe infantile hyperkalaemic periodic paralysis and paramyotonia congenita: broadening the clinical spectrum associated with the T704M mutation in SCN4A. J Neurol Neurosurg Psychiatry (2003) 0.95

Subpopulations of T lymphocytes in myasthenia gravis patients. Clin Exp Immunol (1979) 0.95

Course and treatment of myasthenia gravis during pregnancy. Neurology (1999) 0.94

A new mtDNA mutation associated with a progressive encephalopathy and cytochrome c oxidase deficiency. Neurology (2000) 0.94

Symptoms and neurophysiological picture of carpal tunnel syndrome in pregnancy. Clin Neurophysiol (2001) 0.94

Peroneal mononeuropathy: predisposing factors, and clinical and neurophysiological relationships. Neurol Sci (2000) 0.94

Surgical prognosis in carpal tunnel syndrome: usefulness of a preoperative neurophysiological assessment. Acta Neurol Scand (1996) 0.94

Inhibition of the human primary motor area by painful heat stimulation of the skin. Clin Neurophysiol (1999) 0.94

Treatment with botulinum toxin in a patient with myasthenia gravis and cervical dystonia. Neurology (2005) 0.92

The contribution of magnetic stimulation of the motor cortex to the diagnosis of cervical spondylotic myelopathy. Correlation of central motor conduction to distal and proximal upper limb muscles with clinical and MRI findings. Electroencephalogr Clin Neurophysiol (1992) 0.92

Central nervous system modifications in patients with lesion of the anterior cruciate ligament of the knee. Brain (1996) 0.92

HLA class II allele analysis in MuSK-positive myasthenia gravis suggests a role for DQ5. Neurology (2009) 0.92